A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications-Reference-Cited by-同舟云学术

A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications

Published:2022-07-01 Issue:3 Volume:40 Page:312-326
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Almeida Paulo H.R.F.¹^ORCID,Godman Brian²³⁴^ORCID,dos Santos Nunes-Nogueira Vania⁵^ORCID,de Lemos Lívia L.P.⁶^ORCID,de Assis Acúrcio Francisco¹⁶⁷^ORCID,Guerra-Junior Augusto A.¹⁷^ORCID,de Araújo Vânia E.¹⁷⁸^ORCID,Almeida Alessandra M.¹⁷^ORCID,Alvares-Teodoro Juliana¹⁷^ORCID

Affiliation:

1. 1Graduate Program in Medicines and Pharmaceutical Services, Department of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

2. 2Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, U.K.

3. 3Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

4. 4Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates

5. 5Department of Internal Medicine, São Paulo State University Medical School, São Paulo, Brazil

6. 6Graduate Program in Public Health, Faculty of Medicine, Department of Preventive and Social Medicine, Federal University of Minas Gerais Belo Horizonte, Minas Gerais, Brazil

7. 7SUS Collaborating Centre for Technology Assessment and Excellence in Health, Belo Horizonte, Minas Gerais, Brazil

8. 8Department of Dentistry, Pontifical Catholic University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Abstract

This article describes a cross-sectional study involving 401 adults with type 1 diabetes treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life was assessed, and worse scores were found to be associated with a low level of education, self-perceived health reported as poor/very poor, being bedridden and not physically exercised, having seen a doctor more than four times in the past year, and having reported comorbidities and episodes of hypoglycemia.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/40/3/312/685508/diaclincd210068.pdf

Reference81 articles.

1. Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil: findings and implications;Oliveira;Expert Rev Pharmacoecon Outcomes Res,2017

2. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives;Chan;Lancet,2021

3. 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes—2019;American Diabetes Association;Diabetes Care,2019

4. Global economic burden of diabetes in adults: projections from 2015 to 2030;Bommer;Diabetes Care,2018

5. Insulin and its analogues: what are they for? (pros and cons);Guney;Trends Diabetes Metab,2019